Literature DB >> 33747976

A Comprehensive Analysis of Genomics and Metagenomics in a Heterozygote Familial Hypercholesterolemia Family.

Honghong Liu1, Ye Jin1, Ran Tian1, Siqin Feng1, Shuyang Zhang1, Chenhong Zhang2.   

Abstract

Familial hypercholesterolemia (FH) is an inherited rare disease leading to markedly elevated low-density lipoprotein cholesterol (LDL-C) levels and increased risk for cardiovascular event. Gut microbiota has been implicated as a pivotal contributing factor in hyperlipidemia, however, its role in FH remains elusive. We performed whole-exome and metagenomics sequencing on a family with 22 members in which myocardial infarctions occurred at a young age with unclear etiology. We confirmed the missense mutation of LDLR c.1723C>T accounted for the abnormal cholesterol metabolism in the family through co-segregation analysis. In addition, Prevotella dentalis was found elevated and strongly associated with LDL-C level in FH family members with mutation of LDLR c.1723C>T compared to unaffected members with hyperlipidemia. Overall, our work suggests that whole-exome sequencing can facilitate identification of disease-causing variants and enable preventive treatment of FH. Our metagenomics analysis provides early insights into potential contributions of host-microbe interactions in genetic and common hypercholesterolemia.
Copyright © 2021 Liu, Jin, Tian, Feng, Zhang and Zhang.

Entities:  

Keywords:  LDLR gene mutation; Prevotella dentalis; familial hypercholesterolemia; gut microbiota; whole exome sequencing

Mesh:

Substances:

Year:  2021        PMID: 33747976      PMCID: PMC7966959          DOI: 10.3389/fcimb.2021.605954

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


  30 in total

1.  SIFT: Predicting amino acid changes that affect protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

Review 3.  The role of the microbiota in human genetic adaptation.

Authors:  Taichi A Suzuki; Ruth E Ley
Journal:  Science       Date:  2020-12-04       Impact factor: 47.728

4.  Statin therapy is associated with lower prevalence of gut microbiota dysbiosis.

Authors:  Sara Vieira-Silva; Gwen Falony; Eugeni Belda; Trine Nielsen; Judith Aron-Wisnewsky; Rima Chakaroun; Sofia K Forslund; Karen Assmann; Mireia Valles-Colomer; Thi Thuy Duyen Nguyen; Sebastian Proost; Edi Prifti; Valentina Tremaroli; Nicolas Pons; Emmanuelle Le Chatelier; Fabrizio Andreelli; Jean-Phillippe Bastard; Luis Pedro Coelho; Nathalie Galleron; Tue H Hansen; Jean-Sébastien Hulot; Christian Lewinter; Helle K Pedersen; Benoit Quinquis; Christine Rouault; Hugo Roume; Joe-Elie Salem; Nadja B Søndertoft; Sothea Touch; Marc-Emmanuel Dumas; Stanislav Dusko Ehrlich; Pilar Galan; Jens P Gøtze; Torben Hansen; Jens J Holst; Lars Køber; Ivica Letunic; Jens Nielsen; Jean-Michel Oppert; Michael Stumvoll; Henrik Vestergaard; Jean-Daniel Zucker; Peer Bork; Oluf Pedersen; Fredrik Bäckhed; Karine Clément; Jeroen Raes
Journal:  Nature       Date:  2020-05-06       Impact factor: 49.962

5.  Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

Authors:  Marc S Sabatine; Robert P Giugliano; Stephen D Wiviott; Frederick J Raal; Dirk J Blom; Jennifer Robinson; Christie M Ballantyne; Ransi Somaratne; Jason Legg; Scott M Wasserman; Robert Scott; Michael J Koren; Evan A Stein
Journal:  N Engl J Med       Date:  2015-03-15       Impact factor: 91.245

6.  Comparative analysis of the gut microbiota in distinct statin response patients in East China.

Authors:  Baoqing Sun; Luming Li; Xinfu Zhou
Journal:  J Microbiol       Date:  2018-11-27       Impact factor: 3.422

Review 7.  Fatty acid biosynthesis as a target for novel antibacterials.

Authors:  Richard J Heath; Charles O Rock
Journal:  Curr Opin Investig Drugs       Date:  2004-02

8.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.

Authors:  Børge G Nordestgaard; M John Chapman; Steve E Humphries; Henry N Ginsberg; Luis Masana; Olivier S Descamps; Olov Wiklund; Robert A Hegele; Frederick J Raal; Joep C Defesche; Albert Wiegman; Raul D Santos; Gerald F Watts; Klaus G Parhofer; G Kees Hovingh; Petri T Kovanen; Catherine Boileau; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Jan Albert Kuivenhoven; Päivi Pajukanta; Kausik Ray; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2013-08-15       Impact factor: 29.983

9.  Alterations of Gut Microbiota and Blood Lipidome in Gestational Diabetes Mellitus With Hyperlipidemia.

Authors:  He Liu; Li-Long Pan; Siting Lv; Qin Yang; Hao Zhang; Wei Chen; Zhuwu Lv; Jia Sun
Journal:  Front Physiol       Date:  2019-08-06       Impact factor: 4.566

10.  Fast and accurate long-read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2010-01-15       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.